Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
04/17/2025 | CALL | $26.00 | 43,479 | +17,984 | +70.54% |
04/04/2025 | CALL | $25.50 | 11,165 | +8,823 | +376.73% |
04/17/2025 | PUT | $24.00 | 19,848 | +6,598 | +49.80% |
04/04/2025 | CALL | $26.00 | 18,809 | +4,428 | +30.79% |
04/25/2025 | CALL | $27.00 | 11,422 | +3,725 | +48.40% |
01/16/2026 | PUT | $25.00 | 60,629 | +3,038 | +5.28% |
04/17/2025 | PUT | $23.00 | 13,993 | -207 | -1.46% |
05/16/2025 | CALL | $29.00 | 25,668 | -277 | -1.07% |
04/17/2025 | PUT | $25.00 | 44,078 | -303 | -0.68% |
06/20/2025 | PUT | $25.00 | 60,823 | -421 | -0.69% |
06/18/2026 | PUT | $32.00 | 3,769 | -5,093 | -57.47% |
04/17/2025 | CALL | $29.00 | 28,837 | -7,936 | -21.58% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
American Balanced Fund | 1.00% | 56.61M | 2.04B |
Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
03/31 08:56 am
Benzinga
Read moreWhy Pfizer Is My Largest Healthcare Position
03/27 06:45 am
The Motley Fool
Read moreBuying These Dirt-Cheap Stocks Could Be a Brilliant Move
03/22 06:44 am
The Motley Fool
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read more3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025
03/20 09:45 am
The Motley Fool
Read more1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade
03/20 06:17 am
The Motley Fool
Read morePfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion
03/19 10:40 am
Benzinga
Read more5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond
03/17 07:45 am
The Motley Fool
Read moreDown 93%, Is It Finally Time to Buy Moderna?
03/15 04:38 am
The Motley Fool
Read morePfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (UPDATED)
03/13 02:23 pm
Benzinga
Read moreThis Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
03/13 07:30 am
The Motley Fool
Read moreBispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide
03/12 08:48 am
GlobeNewswire Inc.
Read moreBioNTech Surpasses Q4 Revenue Estimates
03/10 08:42 am
The Motley Fool
Read moreGlobal Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc.
03/09 08:30 pm
GlobeNewswire Inc.
Read more3 Top Dividend Stocks to Buy in March
03/08 09:30 am
The Motley Fool
Read moreBALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight
03/04 02:00 pm
GlobeNewswire Inc.
Read more1 Stock Down 43% That Looks Too Cheap to Ignore
03/04 10:45 am
The Motley Fool
Read moreJAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
03/03 02:00 pm
GlobeNewswire Inc.
Read more2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Now
03/02 05:21 am
The Motley Fool
Read more3 Dividend Stocks That Are No-Brainer Buys Right Now
03/01 06:51 am
The Motley Fool
Read moreOPZELURA Continues to Revolutionize Dermatology Market with Strong Market Uptake | DelveInsight
02/28 02:00 pm
GlobeNewswire Inc.
Read moreDerm-Biome’s DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
02/26 11:00 am
GlobeNewswire Inc.
Read moreTALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight
02/24 02:00 pm
GlobeNewswire Inc.
Read moreCD47 Antigen Inhibitors Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight
02/24 02:00 pm
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read morePrediction: These Could Be the Best-Performing Value Stocks Through 2030
02/23 04:26 pm
The Motley Fool
Read more3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold Forever
02/23 05:53 am
The Motley Fool
Read moreEvolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight
02/21 02:00 pm
GlobeNewswire Inc.
Read moreCell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight
02/21 02:00 pm
GlobeNewswire Inc.
Read moreHyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034
02/21 11:00 am
GlobeNewswire Inc.
Read more2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
02/21 06:50 am
The Motley Fool
Read moreAntibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight
02/20 02:00 pm
GlobeNewswire Inc.
Read moreThe Smartest Dividend Stocks to Buy With $1,000 Right Now
02/20 05:45 am
The Motley Fool
Read moreHemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight
02/18 02:00 pm
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? Buy This ETF and Hold It Forever.
02/18 07:15 am
The Motley Fool
Read more3 Things You Need to Know If You Buy Pfizer Today
02/18 05:35 am
The Motley Fool
Read morePfizer's Talzenna/Xtandi Combo Improves Survival Outcomes In Metastatic Castration-Resistant Prostate Cancer
02/14 12:48 pm
Benzinga
Read moreRespiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider
02/13 10:00 am
GlobeNewswire Inc.
Read more3 Brand-Name, Ultra-High-Yield Dividend Stocks Patient Investors Can Confidently Buy With $300 Right Now
02/13 06:06 am
The Motley Fool
Read more3 Dividend Stocks to Double Up on Right Now
02/09 06:43 am
The Motley Fool
Read moreParesthesia Treatment Market Outlook: USD 8.0 Billion by 2034, Growing with an Aging Population and Rising Healthcare Expenditures | Analysis by TMR
02/07 12:39 pm
GlobeNewswire Inc.
Read moreRespiratory Disease Vaccines Market Research Report 2025: Analysis and Forecast (2020-2030) Featuring GSK, Johnson & Johnson Services, Pfizer, Sanofi, Serum Institute of India, SINOVAC Biotech & More
02/06 05:51 am
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review 2024 | Now Available
02/04 12:00 pm
GlobeNewswire Inc.
Read more2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February
02/04 06:06 am
The Motley Fool
Read morePfizer Trial For Colorectal Cancer Treatment Shows Improved Survival In Late-Stage Study
02/03 11:34 am
Benzinga
Read moreOrphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth
02/03 05:52 am
GlobeNewswire Inc.
Read moreRecombinant Chemicals Market to Reach US$ 6.7 Bn by 2034, Driven by Rising Demand for Protein-Based Vaccines & Genetic Disorder Treatments – TMR Analysis
01/31 10:00 am
GlobeNewswire Inc.
Read moreBRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
01/29 02:00 pm
GlobeNewswire Inc.
Read moreI Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.
01/28 07:15 am
The Motley Fool
Read more